These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24543314)

  • 1. Colorimetric determination of viomycin.
    JACKSON AW
    Antibiot Chemother (Northfield); 1954 Dec; 4(12):1210-5. PubMed ID: 24543314
    [No Abstract]   [Full Text] [Related]  

  • 2. [COLORIMETRIC METHOD FOR THE DETERMINATION OF FLORIMYCIN (VIOMYCIN)].
    SIDOROVA AI; CHAIKOVSKAIA SM
    Antibiotiki; 1963 Oct; 8():917-20. PubMed ID: 14136421
    [No Abstract]   [Full Text] [Related]  

  • 3. [QUANTITATIVE METHOD FOR THE DETERMINATION OF FLORIMYCIN (VIOMYCIN) IN CULTURE MEDIUM FLUIDS].
    SIDOROVA AI
    Antibiotiki; 1963 Oct; 8():915-7. PubMed ID: 14136420
    [No Abstract]   [Full Text] [Related]  

  • 4. [A trace antibiotic component of viomycin].
    Lechowski L
    Acta Pol Pharm; 1973; 30(3):331-4. PubMed ID: 4353615
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzyme-coupled immunoassay of viomycin.
    Kitagawa T; Fujitake T; Taniyama H; Aikawa T
    J Antibiot (Tokyo); 1976 Dec; 29(12):1343-5. PubMed ID: 188796
    [No Abstract]   [Full Text] [Related]  

  • 6. 13C-nuclear magnetic magnetic resonance studies on viomycin and its related compounds.
    Kitagawa T; Miura T; Mori K; Taniyama H; Kawano K; Kyogoku Y
    Chem Pharm Bull (Tokyo); 1977 Feb; 25(2):280-4. PubMed ID: 192477
    [No Abstract]   [Full Text] [Related]  

  • 7. The total structure of viomycin, a tuberculostatic peptide antibiotic.
    Bycroft BW; Cameron D; Croft LR; Johnson AW; Webb T; Hassanali-Walji A
    Experientia; 1971 May; 27(5):501-3. PubMed ID: 4332116
    [No Abstract]   [Full Text] [Related]  

  • 8. [A study on sorption purification of florimycin with ion-exchange resins].
    Ivanova LS; Pashel'ko GM; Burakova AI; Fedorovskaia LV; Vishnevskiĭ VM
    Antibiotiki; 1965 Oct; 10(10):872-7. PubMed ID: 4289011
    [No Abstract]   [Full Text] [Related]  

  • 9. The structure of viomycidine.
    Büchi G; Raleigh JA
    J Org Chem; 1971 Apr; 36(7):873-7. PubMed ID: 4323751
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of the specificity of anti-hapten antibody].
    Kitagawa T
    Tanpakushitsu Kakusan Koso; 1987 Sep; (31 Suppl):211-8. PubMed ID: 2827236
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical studies on tuberactinomycin. 3. The chemical structure of viomycin (tuberactinomycin B).
    Noda T; Take T; Nagata A; Wakamiya T; Shiba T
    J Antibiot (Tokyo); 1972 Jul; 25(7):427-8. PubMed ID: 4350196
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of taxonomic characteristics of highly active viomycin-producing mutants of Streptomyces griseus var. purpureus.
    Tyc M; Kadzikiewicz T
    Acta Microbiol Pol B; 1972; 4(4):217-26. PubMed ID: 4345459
    [No Abstract]   [Full Text] [Related]  

  • 13. [Polarographic determination of the content of certain drug substances in the expired air after inhaling them in the form of aerosols].
    Gerasimov AI; Rogozhin BA; Drutstsa PI; Dedova KM; Baiura VF
    Zh Ushn Nos Gorl Bolezn; 1973; 33(6):20-3. PubMed ID: 4362481
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemical and microbiological detection of liberation of antitubercular agents from emulsions and suspension systems. 2. Capreomycin sulfate, viomycin sulfate and kanamycin sulfate].
    Voigt R; Maa Bared AG
    Pharmazie; 1970; 25(5):342-4. PubMed ID: 4318402
    [No Abstract]   [Full Text] [Related]  

  • 15. [STUDIES ON THE ANTIBACTERIAL SPECTRUM AND DETERMINATION OF THE BIOLOGICAL ACTIVITY OF FLORIMYCIN (VIOMYCIN)].
    TEBIAKINA AE; BUIANOVSKAIA IS; CHAIKOVSKAIA SM; SHNEERSON AN
    Antibiotiki; 1963 Oct; 8():901-5. PubMed ID: 14136417
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of sensitivity threshold of Koch's bacillus to viomycin].
    GIUNIO N
    Tuberkuloza; 1955; 7(4):229-38. PubMed ID: 13312091
    [No Abstract]   [Full Text] [Related]  

  • 17. [AN EXAMINATION OF SOME PHARMACODYNAMIC PROPERTIES OF VIOMYCIN].
    JESKE J; SZURSKA H; BORZECKI Z; LASTOWSKI Z
    Ann Univ Mariae Curie Sklodowska Med; 1963; 18():311-7. PubMed ID: 14232845
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on sensitivity determination of Mycobacterium tuberculosis against chemotherapeutic drugs, with reference to various factors affecting the antibiotic activity of kanamycin and viomycin].
    SUGIYAMA I
    Kekkaku; 1960 Mar; 35():179-86. PubMed ID: 13835578
    [No Abstract]   [Full Text] [Related]  

  • 19. [Derivatives of viomycin. V. Di(oxytetracyclinemethyl)viomycin and tri(oxytetracyclinemethyl)viomycin, preparation and properties].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A
    Acta Pol Pharm; 1969; 26(3):237-40. PubMed ID: 4308291
    [No Abstract]   [Full Text] [Related]  

  • 20. The second international reference preparation of viomycin.
    Lightbown JW; Bond JM; Skegg JL
    Bull World Health Organ; 1973; 48(2):219-27. PubMed ID: 4352612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.